Tissue Collection Framework To Improve Outcomes In Solid Tumours

Launched by QUEEN MARY UNIVERSITY OF LONDON · Jun 18, 2018

Keywords

ClinConnect Summary

This clinical trial, titled "Tissue Collection Framework To Improve Outcomes In Solid Tumours," is focused on understanding why some cancers spread and become resistant to treatments. Researchers want to collect tissue samples and blood from patients diagnosed with solid tumors. By analyzing these samples using advanced technologies, they hope to uncover the biological reasons that allow cancer cells to grow and resist therapy. This knowledge could lead to better treatments in the future that not only work more effectively but also help predict which treatments might be best for individual patients.

To participate in this trial, you need to be at least 18 years old and have been diagnosed with a solid tumor while receiving care at Barts Health NHS Trust. This study is currently looking for participants, so if you qualify, you can expect to provide tissue samples during your routine medical care. These samples will be tested and stored for future research. It’s important to note that while participating could help advance cancer treatment, individuals with certain medical conditions or mental health issues may not be eligible. If you have questions about your eligibility or the study, it’s a good idea to speak with your healthcare provider.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Male and female patients over the age of 18 years who have been diagnosed with a solid tumour and who are seen at the Barts Health NHS Trust for clinical management of their tumour.
• • 2. Male or female more than 18 years of age
• • 3. Able to participate in the study.
• • 4. Able to give informed consent.
• • 5. Patients enrolled into other clinical trials may be included into this study
• • Exclusion Criteria
• • 1. Any co-existing medical condition that in the Investigator's judgement will substantially increase the risk associated with the patient's participation in the study
• • 2. Psychiatric disorders or altered mental status precluding understanding of the informed consent process and/or completion of the necessary studies
• • 3. Physical or mental health issues that preclude them from participation